Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.310
+0.020 (1.55%)
Apr 20, 2026, 4:00 PM EDT - Market closed

Bionano Genomics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
15163286434866
Market Cap Growth
43.81%-49.08%-62.68%-80.07%-49.89%48.00%
Enterprise Value
12.1613.1146.8496.68329.82624.23
Last Close Price
1.311.5317.30113.40876.001794.00
PE Ratio
--0.32-0.20-0.28-3.19-11.50
PS Ratio
0.510.581.052.3915.6148.16
PB Ratio
0.320.370.910.901.742.57
P/TBV Ratio
39.480.190.620.671.692.46
P/FCF Ratio
--1.01-0.47-0.68-3.39-11.80
P/OCF Ratio
--1.01-0.47-0.69-3.48-12.04
EV/Sales Ratio
0.430.461.522.6811.8634.72
EV/EBITDA Ratio
--0.56-0.52-0.48-2.71-8.47
EV/EBIT Ratio
--0.39-0.45-0.45-2.50-8.10
EV/FCF Ratio
--0.80-0.68-0.76-2.58-8.51
Debt / Equity Ratio
0.360.360.680.800.040.03
Debt / EBITDA Ratio
0.00-0.72-0.30-0.39-0.10-0.14
Debt / FCF Ratio
-1.03-1.03-0.39-0.63-0.09-0.15
Net Debt / Equity Ratio
-0.05-0.050.500.13-0.41-0.71
Net Debt / EBITDA Ratio
00.10-0.20-0.060.833.25
Net Debt / FCF Ratio
0.140.14-0.26-0.100.793.27
Asset Turnover
-272.980.380.210.140.080.08
Inventory Turnover
-1296.991.851.791.011.041.80
Quick Ratio
1.071.070.380.763.3511.70
Current Ratio
1.981.981.061.404.3812.47
Return on Equity (ROE)
46158.80%-66.15%-170.33%-134.56%-45.21%-38.92%
Return on Assets (ROA)
32994.50%-44.49%-71.47%-82.51%-39.03%-32.66%
Return on Invested Capital (ROIC)
50661.30%-68.31%-113.21%-143.35%-96.00%-118.54%
Return on Capital Employed (ROCE)
55008.10%-74.11%-135.31%-111.53%-42.02%-37.91%
Earnings Yield
-181.66%-316.99%-509.42%-360.32%-31.37%-8.70%
FCF Yield
-112.49%-99.47%-213.89%-146.72%-29.50%-8.48%
Buyback Yield / Dilution
-328.40%-328.40%-123.37%-18.05%-4.49%-165.50%
Total Shareholder Return
-328.40%-328.40%-123.37%-18.05%-4.49%-165.50%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q